319 related articles for article (PubMed ID: 33207947)
1. Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.
Alshehri S; Imam SS; Hussain A; Altamimi MA; Alruwaili NK; Alotaibi F; Alanazi A; Shakeel F
Drug Deliv; 2020 Nov; 27(1):1625-1643. PubMed ID: 33207947
[TBL] [Abstract][Full Text] [Related]
2. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
Vo CL; Park C; Lee BJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
[TBL] [Abstract][Full Text] [Related]
3. An Overview on Recent Patents and Technologies on Solid Dispersion.
Kaushik R; Budhwar V; Kaushik D
Recent Pat Drug Deliv Formul; 2020; 14(1):63-74. PubMed ID: 31951172
[TBL] [Abstract][Full Text] [Related]
4. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs.
Kumar S; Gupta SK
Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):111-21. PubMed ID: 23331062
[TBL] [Abstract][Full Text] [Related]
6. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
7. Solid dispersion technology as a strategy to improve the bioavailability of poorly soluble drugs.
Cid AG; Simonazzi A; Palma SD; Bermúdez JM
Ther Deliv; 2019 Jun; 10(6):363-382. PubMed ID: 31094298
[TBL] [Abstract][Full Text] [Related]
8. Solubilization of poorly water-soluble drugs using solid dispersions.
Tran TT; Tran PH; Khanh TN; Van TV; Lee BJ
Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):122-33. PubMed ID: 23244679
[TBL] [Abstract][Full Text] [Related]
9. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
Bikiaris DN
Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
[TBL] [Abstract][Full Text] [Related]
10. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
11. Delivery of poorly soluble compounds by amorphous solid dispersions.
Lee TW; Boersen NA; Hui HW; Chow SF; Wan KY; Chow AH
Curr Pharm Des; 2014; 20(3):303-24. PubMed ID: 23651395
[TBL] [Abstract][Full Text] [Related]
12. Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates.
Alam MA; Ali R; Al-Jenoobi FI; Al-Mohizea AM
Expert Opin Drug Deliv; 2012 Nov; 9(11):1419-40. PubMed ID: 23043303
[TBL] [Abstract][Full Text] [Related]
13. Towards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers.
Penkina A; Semjonov K; Hakola M; Vuorinen S; Repo T; Yliruusi J; Aruväli J; Kogermann K; Veski P; Heinämäki J
Drug Dev Ind Pharm; 2016; 42(3):378-88. PubMed ID: 26065533
[TBL] [Abstract][Full Text] [Related]
14. Application of hot melt extrusion for poorly water-soluble drugs: limitations, advances and future prospects.
Lu M; Guo Z; Li Y; Pang H; Lin L; Liu X; Pan X; Wu C
Curr Pharm Des; 2014; 20(3):369-87. PubMed ID: 23651401
[TBL] [Abstract][Full Text] [Related]
15. Emerging trends in the stabilization of amorphous drugs.
Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on Strategies Using Swellable Polymers in Solid Dispersions for Controlled Drug Release.
Tran TTD; Tran PHL
Curr Pharm Des; 2017; 23(11):1639-1648. PubMed ID: 27774901
[TBL] [Abstract][Full Text] [Related]
17. Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating Formulations.
Sun DD; Lee PI
AAPS J; 2015 Nov; 17(6):1317-26. PubMed ID: 26338234
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of drug load and polymer by using a 96-well plate vacuum dry system for amorphous solid dispersion drug delivery.
Chiang PC; Ran Y; Chou KJ; Cui Y; Sambrone A; Chan C; Hart R
AAPS PharmSciTech; 2012 Jun; 13(2):713-22. PubMed ID: 22562615
[TBL] [Abstract][Full Text] [Related]
19. Designing an ADME liquid formulation with matching exposures to an amorphous dosage form.
Xi H; Yang Z; Tatavarti A; Xu W; Fuerst J; Ormes J
Int J Pharm; 2019 Jan; 554():48-53. PubMed ID: 30236644
[TBL] [Abstract][Full Text] [Related]
20. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
